Under the FDA's 510(k) premarket notification pathway, a cosmetic surgeon seeking to use a new energy-based device must demonstrate that the device is:
-
A
Substantially equivalent to a legally marketed predicate device
-
B
Superior in efficacy to all existing devices
-
C
Approved by the American Board of Cosmetic Surgery
-
D
Exempt from all clinical trial requirements